[Skip to Navigation]
Sign In
Figure.  Flowchart of Study Population
Flowchart of Study Population

AGH indicates Annecy General Hospital; GUH, Grenoble University Hospital; ICD-10, International Statistical Classification of Diseases and Related Health Problems, Tenth Revision.

Table 1.  Population Characteristics
Population Characteristics
Table 2.  Performance of the Reviewers
Performance of the Reviewers
Table 3.  Primary Reason Rated by Reviewers
Primary Reason Rated by Reviewers
Table 4.  Unadjusted Comparison of Factors Associated With Readmission
Unadjusted Comparison of Factors Associated With Readmission
1.
Leppin  AL, Gionfriddo  MR, Kessler  M,  et al.  Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials.   JAMA Intern Med. 2014;174(7):1095-1107. doi:10.1001/jamainternmed.2014.1608PubMedGoogle ScholarCrossref
2.
US Centers for Medicare & Medicaid Services. Hospital Readmissions Reduction Program (HRRP). Revised December 1, 2021. Accessed May 15, 2021. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program
3.
Fonarow  GC, Yancy  CW.  Consequences of reductions in hospital readmissions.   JAMA. 2017;318(19):1933-1934. doi:10.1001/jama.2017.14779PubMedGoogle ScholarCrossref
4.
Fontanarosa  PB, McNutt  RA.  Revisiting hospital readmissions.   JAMA. 2013;309(4):398-400. doi:10.1001/jama.2013.42PubMedGoogle ScholarCrossref
5.
US Centers for Medicare & Medicaid Services. Hospital-Wide (All-Condition) 30-Day Risk-Standardized Readmission Measure. Updated August 10, 2011. Accessed February 15, 2022. https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/mms/downloads/mmshospital-wideall-conditionreadmissionrate.pdf
6.
Gusmano  M, Rodwin  V, Weisz  D, Cottenet  J, Quantin  C.  Comparison of rehospitalization rates in France and the United States.   J Health Serv Res Policy. 2015;20(1):18-25. doi:10.1177/1355819614551849PubMedGoogle ScholarCrossref
7.
Shorr  AF, Zilberberg  MD.  Admitting what we do not know about pneumonia readmissions.   Chest. 2015;148(1):4-6. doi:10.1378/chest.14-2987PubMedGoogle ScholarCrossref
8.
Andruska  A, Micek  ST, Shindo  Y,  et al.  Pneumonia pathogen characterization is an independent determinant of hospital readmission.   Chest. 2015;148(1):103-111. doi:10.1378/chest.14-2129PubMedGoogle ScholarCrossref
9.
van Walraven  C, Jennings  A, Taljaard  M,  et al.  Incidence of potentially avoidable urgent readmissions and their relation to all-cause urgent readmissions.   CMAJ. 2011;183(14):E1067-E1072. doi:10.1503/cmaj.110400PubMedGoogle ScholarCrossref
10.
Lindenauer  PK, Normand  S-LT, Drye  EE,  et al.  Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia.   J Hosp Med. 2011;6(3):142-150. doi:10.1002/jhm.890PubMedGoogle ScholarCrossref
11.
Weinreich  M, Nguyen  OK, Wang  D,  et al.  Predicting the risk of readmission in pneumonia—a systematic review of model performance.   Ann Am Thorac Soc. 2016;13(9):1607-1614. doi:10.1513/AnnalsATS.201602-135SRPubMedGoogle ScholarCrossref
12.
Dely  C, Sellier  P, Dozol  A, Segouin  C, Moret  L, Lombrail  P.  Les réadmissions évitables des pneumopathies communautaires: utilité et fiabilité d’un indicateur de la qualité du parcours de soins du patient.   Presse Med. 2012;41(1):e1-e9. doi:10.1016/j.lpm.2011.06.007PubMedGoogle ScholarCrossref
13.
Shams  I, Ajorlou  S, Yang  K.  A predictive analytics approach to reducing 30-day avoidable readmissions among patients with heart failure, acute myocardial infarction, pneumonia, or COPD.   Health Care Manag Sci. 2015;18(1):19-34. doi:10.1007/s10729-014-9278-yPubMedGoogle ScholarCrossref
14.
Yap  V, Mutneja  R, Metersky  M.  Thirty-day readmissions after pneumonia: how many are preventable?   Conn Med. 2016;80(3):147-151.PubMedGoogle Scholar
15.
Auerbach  AD, Kripalani  S, Vasilevskis  EE,  et al.  Preventability and causes of readmissions in a national cohort of general medicine patients.   JAMA Intern Med. 2016;176(4):484-493. doi:10.1001/jamainternmed.2015.7863PubMedGoogle ScholarCrossref
16.
Herzig  SJ, Schnipper  JL, Doctoroff  L,  et al.  Physician perspectives on factors contributing to readmissions and potential prevention strategies: a multicenter survey.   J Gen Intern Med. 2016;31(11):1287-1293. doi:10.1007/s11606-016-3764-5PubMedGoogle ScholarCrossref
17.
van Walraven  C, Jennings  A, Forster  AJ.  A meta-analysis of hospital 30-day avoidable readmission rates.   J Eval Clin Pract. 2012;18(6):1211-1218. doi:10.1111/j.1365-2753.2011.01773.xPubMedGoogle ScholarCrossref
18.
Mounayar  A-L, Francois  P, Pavese  P,  et al.  Development of a risk prediction model of potentially avoidable readmission for patients hospitalised with community-acquired pneumonia: study protocol and population.   BMJ Open. 2020;10(11):e040573. doi:10.1136/bmjopen-2020-040573PubMedGoogle Scholar
19.
Halfon  P, Eggli  Y, van Melle  G, Chevalier  J, Wasserfallen  J-B, Burnand  B.  Measuring potentially avoidable hospital readmissions.   J Clin Epidemiol. 2002;55(6):573-587. doi:10.1016/S0895-4356(01)00521-2PubMedGoogle ScholarCrossref
20.
Fonarow  GC, Yancy  CW.  Claims data to ascertain clinical events: lost in translation.   JAMA Cardiol. 2017;2(7):758. doi:10.1001/jamacardio.2017.1580PubMedGoogle ScholarCrossref
21.
Kangovi  S, Grande  D.  Hospital readmissions—not just a measure of quality.   JAMA. 2011;306(16):1796-1797. doi:10.1001/jama.2011.1562PubMedGoogle ScholarCrossref
22.
van Walraven  C, Bennett  C, Jennings  A, Austin  PC, Forster  AJ.  Proportion of hospital readmissions deemed avoidable: a systematic review.   CMAJ. 2011;183(7):E391-E402. doi:10.1503/cmaj.101860PubMedGoogle ScholarCrossref
23.
Yam  CHK, Wong  ELY, Chan  FWK, Wong  FYY, Leung  MCM, Yeoh  EK.  Measuring and preventing potentially avoidable hospital readmissions: a review of the literature.   Hong Kong Med J. 2010;16(5):383-389.PubMedGoogle Scholar
24.
Ashton  CM, Wray  NP.  A conceptual framework for the study of early readmission as an indicator of quality of care.   Soc Sci Med. 1996;43(11):1533-1541. doi:10.1016/S0277-9536(96)00049-4PubMedGoogle ScholarCrossref
25.
Capelastegui  A, España  PP, Bilbao  A,  et al.  Pneumonia: criteria for patient instability on hospital discharge.   Chest. 2008;134(3):595-600. doi:10.1378/chest.07-3039PubMedGoogle ScholarCrossref
26.
Capelastegui  A, España Yandiola  PP, Quintana  JM,  et al.  Predictors of short-term rehospitalization following discharge of patients hospitalized with community-acquired pneumonia.   Chest. 2009;136(4):1079-1085. doi:10.1378/chest.08-2950PubMedGoogle ScholarCrossref
27.
Halm  EA, Fine  MJ, Kapoor  WN, Singer  DE, Marrie  TJ, Siu  AL.  Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia.   Arch Intern Med. 2002;162(11):1278-1284. doi:10.1001/archinte.162.11.1278PubMedGoogle ScholarCrossref
28.
Hatipoğlu  U, Wells  BJ, Chagin  K, Joshi  D, Milinovich  A, Rothberg  MB.  Predicting 30-day all-cause readmission risk for subjects admitted with pneumonia at the point of care.   Respir Care. 2018;63(1):43-49. doi:10.4187/respcare.05719PubMedGoogle ScholarCrossref
29.
Pederson  JL, Warkentin  LM, Majumdar  SR, McAlister  FA.  Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: a systematic review and meta-analysis.   J Hosp Med. 2016;11(5):373-380. doi:10.1002/jhm.2547PubMedGoogle ScholarCrossref
30.
Rudolph  BA, Miller  N.  Cost of care for diabetes in Wisconsin hospitals and ambulatory surgery centers in 1996.   WMJ. 1998;97(3):55-57.PubMedGoogle Scholar
31.
Shorr  AF, Zilberberg  MD, Reichley  R,  et al.  Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals.   Clin Infect Dis. 2013;57(3):362-367. doi:10.1093/cid/cit254PubMedGoogle ScholarCrossref
32.
Chin  DL, Bang  H, Manickam  RN, Romano  PS.  Rethinking thirty-day hospital readmissions: shorter intervals might be better indicators of quality of care.   Health Aff (Millwood). 2016;35(10):1867-1875. doi:10.1377/hlthaff.2016.0205PubMedGoogle ScholarCrossref
33.
Sauro  K, Ghali  WA, Stelfox  HT.  Measuring safety of healthcare: an exercise in futility?   BMJ Qual Saf. 2020;29(4):341-344. doi:10.1136/bmjqs-2019-009824PubMedGoogle ScholarCrossref
34.
Boussat  B, Quan  H, Labarere  J, Southern  D, Couris  CM, Ghali  WA.  Mitigating imperfect data validity in administrative data PSIs: a method for estimating true adverse event rates.   Int J Qual Health Care. 2021;33(1):mzab025. doi:10.1093/intqhc/mzab025PubMedGoogle Scholar
35.
Makam  AN, Nguyen  OK, Clark  C,  et al.  Predicting 30-day pneumonia readmissions using electronic health record data.   J Hosp Med. 2017;12(4):209-216. doi:10.12788/jhm.2711PubMedGoogle ScholarCrossref
36.
Fairie  P, Zhang  Z, D’Souza  AG, Walsh  T, Quan  H, Santana  MJ.  Categorising patient concerns using natural language processing techniques.   BMJ Health Care Inform. 2021;28(1):e100274. doi:10.1136/bmjhci-2020-100274PubMedGoogle Scholar
37.
Lee  S, Doktorchik  C, Martin  EA,  et al.  Electronic medical record-based case phenotyping for the Charlson conditions: scoping review.   JMIR Med Inform. 2021;9(2):e23934. doi:10.2196/23934PubMedGoogle Scholar
38.
Burke  RE, Jones  CD, Hosokawa  P, Glorioso  TJ, Coleman  EA, Ginde  AA.  Influence of nonindex hospital readmission on length of stay and mortality.   Med Care. 2018;56(1):85-90. doi:10.1097/MLR.0000000000000829PubMedGoogle ScholarCrossref
Original Investigation
Pulmonary Medicine
April 8, 2022

Incidence of Avoidable 30-Day Readmissions Following Hospitalization for Community-Acquired Pneumonia in France

Author Affiliations
  • 1Service d’épidémiologie et évaluation médicale, CHU Grenoble-Alpes, Grenoble, France
  • 2Laboratoire TIMC-IMAG, UMR 5525 Joint Research Unit, Centre National de Recherche Scientifique, Université Grenoble-Alpes, France
  • 3O’Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada
  • 4Service des maladies infectieuses, CHU Grenoble-Alpes, Grenoble, France
  • 5Service d’information médicale, CHU Grenoble-Alpes, Grenoble, France
  • 6Service d’information et d’évaluation médicale, Centre hospitalier Annecy-Genevois, Épagny-Metz-Tessy, France
  • 7Service de pneumologie, CHU Grenoble-Alpes, Grenoble, France
  • 8Service des maladies infectieuses, Centre hospitalier Annecy-Genevois, Épagny-Metz-Tessy, France
JAMA Netw Open. 2022;5(4):e226574. doi:10.1001/jamanetworkopen.2022.6574
Key Points

Question  How many 30-day readmissions following hospitalization for community-acquired pneumonia are avoidable?

Findings  In a cohort study including 1150 index hospital stays with a diagnosis of community-acquired pneumonia, multiple physician review analyzed by latent class analysis found only 15 readmissions were avoidable (13.9% of the 108 unplanned readmissions).

Meaning  The low rate of avoidable readmissions found in this study contradicts the logic of the Hospital Readmission Reduction Program, which is based upon the notion that they should be mostly avoidable.

Abstract

Importance  Rates of 30-day readmissions following hospitalization for pneumonia are used to publicly report on hospital performance and to set financial penalties for the worst-performing hospitals. However, the rate of avoidable readmission following hospitalization for pneumonia is undefined.

Objective  To assess how often 30-day readmissions following hospitalization for community-acquired pneumonia (CAP) are avoidable.

Design, Setting, and Participants  This cohort study analyzed the results of an independent review of readmissions following hospitalization for CAP within 30 days among patients discharged from 2 large hospitals in France in 2014. Structured clinical records including clinical information (ie, baseline characteristics, physical examination, laboratory findings, x-ray or computed tomography scan findings, discharge plan, and treatments) for both index and readmission stays were independently reviewed by 4 certified board physicians. All consecutive adult patients hospitalized in 2014 with a diagnosis of CAP in our 2 eligible hospitals were eligible. All analyses presented were performed in March 2021.

Main Outcomes and Measures  Avoidable readmission within 30 days of discharge from index hospitalization. The likelihood that a readmission was avoidable was quantified using latent class analysis based on the independent reviews. A readmission was considered avoidable if Bayes posterior probability exceeded 50%.

Results  The total analytical sample consisted of 1150 index hospital stays with a diagnosis of CAP, which included 651 (56.6%) male patients. The median (IQR) age for all patients was 77.8 (IQR, 62.7-86.4) years. Out of the 1150 index hospital stays, 98 patients (8.5%) died in hospital, and 108 (9.4%) unplanned readmissions were found. Overall, 15 readmissions had a posterior probability of avoidability exceeding 0.50 (13.9% of the 108 unplanned readmissions; 95% CI, 8.0%-21.9%). The median (IQR) delay between the hospital discharge index and readmission was considerably shorter when readmission was deemed avoidable (4 [6-21] days vs 12 [2-18] days; P = .02).

Conclusions and Relevance  Only a small number of readmissions following hospitalization for CAP were deemed avoidable, comprising less than 10% of all readmissions. Shorter time interval between hospitalization discharge and readmission was associated with avoidability.

Introduction

In the US, the Centers for Medicare & Medicaid Services (CMS) began using pneumonia readmission as a core metric in pay-for-performance programs on October 1, 2012.1 In the Hospital Readmission Reduction Program (HRRP), hospitals with higher than expected 30-day readmission rates for patients with several target conditions, including pneumonia, have their CMS payments reduced.2 The underlying logic of the HRRP is based upon the notion that short-term readmission is often an avoidable adverse outcome reflecting suboptimal quality of care during index hospitalization. Numerous flaws have been reported, including that deaths without hospitalization favorably affect the HRRP metric, and that the prediction model uses only hospital claims data with imperfect validity.3,4 In Europe, England, Germany, Denmark, and France have introduced pay-for-performance programs that include 30-day readmission rates as a core metric and are therefore exposed to similar flaws.5,6

Shorr et al7 reported other flaws concerning pneumonia readmission. Given the complex specificity of pneumonia, some hospital readmissions are unavoidable. For example, certain pathogens have been shown to be associated with higher rates of rehospitalization.8 More generally, the HRRP readmission model cannot adequately account for medical complexity, as many pieces of information are missing from hospital claims databases. The rate of readmissions deemed avoidable is an open question, especially if it must be high enough for readmission to be considered as a reliable quality-of-care measure.9

Solid evidence about the true rates and determinants of avoidable pneumonia readmissions are lacking in prior studies. Several models have sought out correlation with baseline characteristics but have not been able to precisely identify the circumstances of readmission that could be deemed avoidable.10,11 Moreover, most of the studies aimed at assessing avoidability have not used recommended guidelines and have reported heterogeneous results.12-16 Subjectivity always exists when determining the extent to which readmissions are avoidable, despite guidelines intended to minimize error. To counteract this, the parameters required for reviewing readmissions must include precise clinical information, and multiple reviewers are essential when dealing with avoidability.17

Through a multicenter cohort study of hospitalized patients diagnosed with community-acquired pneumonia (CAP), we aimed to identify the proportion of pneumonia readmissions that might justifiably be deemed avoidable. We performed multiple reviews and, using latent class models, calculated the likelihood that readmission of a given patient was indeed avoidable. In addition, we carried out an analysis of the potential factors associated with avoidability. We hypothesized that a significant proportion of readmissions were nonavoidable.

Methods
Study Design and Settings

This retrospective, observational cohort study was conducted at a university-affiliated hospital and a general hospital in France. The first, the Grenoble University Hospital, has 1362 acute care beds. The second is Annecy General Hospital, with 660 acute care beds. The rationale, methods, and study sample have been reported in detail elsewhere.18 The protocol for this study was approved by the Comité de Protection des Personnes Sud-Est V. The consent for data collection through medical record review and the use of corresponding administrative discharge data was sought under a regime of nonopposition (ie, patient opt-out): after appropriate written information is delivered by regular mail, data were collected except in case of opposition from the patient. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.

Population

We included all consecutive adult patients aged 18 years or older hospitalized in 2014 in either hospital with a CAP diagnosis. Eligible stays included adult patients (ie, over age 18 years) with an International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) code of main diagnosis, related diagnosis, or significant associated diagnosis of low acute respiratory infection (eTable 1 in the Supplement).

After data entry, we excluded cases of lower respiratory infection without CAP in accordance with the following diagnostic criteria: diagnosis clearly mentioned in the hospital report; patient record contained a notation of 1 or more respiratory symptoms (cough, sputum production, dyspnea, tachypnea, or pleuritic pain), 1 or more auscultation findings (rale or crepitation), and 1 or more signs of infection (temperature above 38 °C, shivering, or white blood cell count below 4 or above 10 Giga/L), and a new pulmonary infiltrate on chest x-ray or computed tomography (CT) scan. For each included stay, the first all-cause readmission within 1 year of discharge was included, regardless of the main, related, or significant associated diagnosis.

Data Collection

Data sources included patient electronic medical records and hospital discharge administrative data. To ensure optimal quality, 2 clinical research assistants entered all data collected electronically using a structured clinical record and a protected web-based data collection system. The clinical research assistants had received formal training in the methods of data abstraction and recording.

The following variables were recorded for each index hospitalization: patient and hospital stay identifiers; baseline patient characteristics, including demographics, preexisting comorbid conditions, pneumonia severity index risk class, physical examination and laboratory findings on admission, x-ray or CT scan findings within 48 hours of admission, and initial microbiological work-up; in-hospital antibiotic therapy and associated treatments; index hospital admission course (intensive care unit [ICU] admission, pneumonia-related and unrelated complications); physical examination and laboratory findings at discharge; and discharge plan and treatments.

Furthermore, the following variables were recorded for the first all-cause readmission within 1 year of discharge: patient and hospital stay identifiers; physical examination and laboratory findings on readmission, x-ray or CT scan findings within 48 hours of readmission; ICU admission; pneumonia-related and unrelated complications; and primary and secondary reasons for readmissions.

Physician Reviews

Data on hospital stays with confirmed CAP with readmission within 30 days of discharge were submitted to 4 medical experts to evaluate the unplanned nature of readmission, its avoidable nature, and the causes of readmissions. We recruited a convenience sample of 9 board-certified physicians with experience in managing CAP, including 3 infectious disease specialists, 3 pulmonologists, and 3 clinical epidemiology specialists. Four panelists reviewed all readmission cases, including at least 1 infectious disease specialist, 1 pulmonologist, and 1 clinical epidemiologist (ie, the fourth panelist was either an infectious disease specialist, a pulmonologist or an epidemiologist). Cases were randomly assigned to each expert. To prevent evaluation bias, a clinical research assistant checked discharge letters and prescriptions to identify the physician in charge of the patient’s care. If one of the randomly selected reviewers was identified as in charge for the hospitalization, another reviewer from the same specialty replaced him or her. The panelists were requested to independently review medical records for both index hospitalization and readmission.

For nature of readmission, reviewers assessed the planned or unplanned nature of the readmission. When the 4 experts disagreed, a fifth expert was asked to decide on the planned or unplanned nature of the readmission. Investigation for planned readmissions did not go further. Consistent with van Walraven et al,9 reviewers used a 6-point ordinal scale to determine whether the readmission was an adverse event and whether the readmission could have been avoided (eTable 2 in the Supplement). A readmission with a rating above 3 in both domains was classified as avoidable. The panelists also assigned the primary reason for each readmission (regardless of avoidability) using 11 mutually exclusive categories19: unforeseen readmission for a new affection, complication of surgical care, complication of nonsurgical care, drug-related adverse event, premature discharge, discharge with a missing or erroneous diagnosis or therapy, other type of inadequate discharge, failure of postdischarge follow-up care, inadequate patient behavior, relapse or aggravation of a previously known condition, and social readmission.

Outcome Measure

The primary outcome measure was avoidable readmission within 30 days of discharge from index hospitalization. The likelihood that a readmission was avoidable was quantified using latent class analysis based on the independent reviews by 4 panelists. A readmission was considered avoidable if Bayes posterior probability exceeded 0.50.9

Statistical Analysis

We used descriptive statistics for reporting continuous (mean or median) and categorical (numbers and percentages) variables. We performed latent class analysis to quantify the probability that a readmission was avoidable, based on the independent classification by 4 panelists. The same approach was previously used by others.9 Briefly, latent class analysis is a statistical approach that assigns individuals to 2 or more latent classes (in our case, true avoidability) based on a set of observed categorical variables (in our case, avoidability rated by multiple reviews). The latent variable cannot be observed directly; instead, it is measured indirectly by using multiple observed variables.

We specified a 2-class model that reflects the dichotomy of avoidable vs unavoidable readmission. The independent classification of readmission conducted by each of the 4 experts was entered as observed categorical variables. We derived from the latent class model a Bayes posterior probability of avoidability for each individual case of readmission. The model-based sensitivity, specificity, and Youden index of each expert’s classification of readmissions as avoidable was calculated.

Patient-stay characteristics were compared between avoidable and nonavoidable readmissions using the χ2 test or Fisher exact test where appropriate for categorical variables and the t test or nonparametric Wilcoxon test for continuous variables. A 2-sided P < .05 was considered statistically significant. All statistical analyses were performed in 2021 using Stata Standard Edition version 16 (StataCorp).

Results
Patient Characteristics

From January 1, 2014, to December 31, 2014, 1523 hospital stays with an ICD-10 diagnosis code of pneumonia were identified (Figure). After removing 186 hospital stays based on our exclusion criteria and 187 hospital stays with a diagnosis other than CAP, our analytical sample consisted of 1150 index hospital stays. The median (IQR) age of these patients was 77.8 (IQR 62.7-86.4) years, and 651 patients (56.6%) were men. Overall, 98 patients (8.5%) died in hospital and 184 were readmitted within 30 days of discharge, representing an early readmission rate of 17.5% (184 of 1052 patients; 95% CI, 15.2%-19.9%). Out of these 184 stays, 108 were classified by the panelists as unplanned and were included in the avoidability analysis (10.3% of discharges; 95% CI, 8.6%-12.3%; 58.7% of readmissions; 95% CI, 51.5%-65.6%).

Among the 108 unplanned readmissions, the patient median age was 77.8 (65-86) years, 44 (40.7%) were women and 16 (15.0%) were nursing home residents. Median length of stay of index hospitalization was 9 (6-14) days (Table 1). A vast majority of the population had high-risk classes (IV-V) in the pneumonia severity index (72 patients [66.7%]).

Avoidable Readmissions

After physician review of the 108 patients with CAP, 15 readmissions had a posterior probability of avoidability exceeding 0.50 (13.9%; 95% CI, 8.0%-21.9%). The mean of the 108 posterior probabilities was 13.6% (95% CI, 7.9-19.2). This exact fit between the proportion of readmissions with posterior probabilities exceeding 0.50 and the mean validated the fit of the latent class model. Eighty-five of the 108 unscheduled readmissions (78.7%) had a probability of being avoidable of less than 10% (eFigure in the Supplement).

Only 51 cases of unplanned readmissions (47.2%) presented perfect agreement between the 4 independent reviewers. Among these 51 cases, only 1 was classified as avoidable. The latent class model was also used to assess the individual performance of the 9 reviewers (Table 2). Mean sensitivity was 0.67 (range, 0.20-0.99) and mean specificity was 0.84 (range, 0.49-0.99).

Primary Reason for Readmission

The main causes readmission were relapse or aggravation of a previously known affection (40.1%) and unforeseen readmission for a new affection (24.5%) (Table 3). For readmissions assessed as avoidable, the main reason was a situation involving discharge with a missing or erroneous diagnosis or therapy (19 readmissions [31.7%]). Premature discharge (11 of 60 avoidable readmissions [18.3%] vs 10 of 372 nonavoidable readmissions [2.7%]; P < .001) and discharge with missing or erroneous diagnosis or therapy (19 avoidable readmissions [31.7%] vs [5.7%]; P < .001) were associated with avoidability.

Factors Associated With Avoidability

The median (IQR) delay between the index hospitalization discharge and the readmission was notably shorter when the readmission was deemed avoidable (4 [6-21] days vs 12 [2-18] days, P = .02) (Table 4). None of the other factors related to preadmission, functional and cognitive status, and postdischarge were found as significantly associated with avoidability.

Discussion

Our multicenter cohort study showed that only a small proportion of hospital readmissions following hospitalization for pneumonia were avoidable. Less than one-fifth of all unplanned readmissions and less than one-tenth of all readmissions, respectively, were deemed to be avoidable. Furthermore, readmissions deemed avoidable occurred much earlier than those considered nonavoidable.

There has long been discomfort around the use of 30-day readmission rates derived from administrative data, because it is widely known that such automatic indicators do not account for the complexity of clinical situations and thus represent an incomplete capture of low quality of care at the hospital level.3,4,7,20-22 The low rate of avoidable readmissions that we found contradicts the logic of the HRRP program, which is based upon the notion that they should be mostly avoidable. By contrast, our main finding is in line with other studies investigating the rate of avoidable readmissions for pneumonia, which ranged from 6.3% to 12.5%.12-16,23 Nevertheless, these studies were characterized by heterogeneous approaches to defining key terms, data collection, and data analysis.

The novelty of our study consisted of the use of multiple and independent medical record review, and of latent class analysis that was applied to readmissions of patients with pneumonia. The need to apply this method was illustrated by the difficulty for different experts to come to a concordant conclusion regarding avoidable readmission. Even with detailed and exhaustive clinical information, judgements about avoidability varied among reviewers (ie, sensitivity and specificity). A large number of complex factors can potentially influence readmission to the hospital.15,16,24-31 Clinical cases of pneumonia are complex, involving a majority of older patients with comorbidities. In some cases, patients are facing difficult social situations, which are known to affect discharge and follow-up. While these considerations remain hypothetical, they show that an algorithm based solely on medico-administrative data cannot be relevant enough to assess whether readmission is avoidable or not.

A secondary objective was to identify factors associated with avoidable readmissions. The difference in time from hospital discharge to readmission was significantly lower in the avoidable readmission group. This finding corroborates doubts about the pertinence of the 30-day readmission interval used by the HRRP program. In 2016, Chin and colleagues32 reported that the hospital-level quality signal captured in pneumonia readmission risk was highest between the first and the seventh day postdischarge. Shorr et al31 suggested that a longer time interval found a majority of readmissions related to preexistent comorbidity relapse, the patient’s social situation, and residence in nursing home. In our study, we likewise found that a majority of nonavoidable readmissions were caused by a relapse or aggravation of a previously known affection, and that it concerned only a small proportion of avoidable readmissions.

Adverse event detection and measurement is inherently difficult and there is no failsafe method to capture events.33 Given the use of 30-day readmission as an indicator for financial penalties and public reporting, our study suggests that the HRRP indicators may unfairly penalize hospitals financially and lower their reputation. The weakness we report here should be considered by health organizations in light of the other previously reported flaws of the 30-day readmission indicators. Several choices are available to policy makers. A first approach would be to avoid reporting of quality using this indicator, which is far from ideal given the limited number of quality-of-care indicators available to health systems. A second would be to structure national reporting systems around the general approach used in this study, ie, a consensus-based expert review of readmissions. However, reviewing manual records is laborious, and the need for multiple and independent experts raises questions about feasibility and opportunity costs.34 A third option would be to develop a risk prediction model designed to identify avoidable 30-day readmission of patients hospitalized with pneumonia. However, in order to report a high number of avoidable rehospitalizations and to attain power sufficient to identify factors associated with avoidability, it would be necessary to conduct the same type of study on a larger number of hospitals. While this option remains possible, it would also require more detailed clinical information than is available in administrative claims-based data.35 That said, the generalization of digital health records at the hospital level and the development of artificial intelligence algorithms applied to electronic medical records could create a pathway to automated clinical prediction models in the near future.36,37

Limitations

The present study has several important limitations. First, we included patients using administrative claims database specific to the 2 index hospitals and we were unable to capture readmissions in other hospitals. Burke et al38 estimated that 20% of 30-day readmissions occur at nonindex hospitals, and that nonindex readmissions had slightly different characteristics in comparison with index readmissions. Therefore, our avoidability analysis might be different if applied to nonindex readmission. Second, we did not manage to identify clinical factors associated with readmissions deemed avoidable, with the exception of time to readmission. Nevertheless, this limitation should be considered in light of our primary outcome regarding the low proportion of avoidable readmissions. We did not expect to observe such a low proportion, which limited the power of the analyses planned in the original protocol. In addition, the low proportion did not make possible the multivariate analysis of time to readmission found to be significantly associated with avoidability in univariate analysis. We cannot therefore exclude that this association was not due to confounding factors, such as patient severity or other characteristics related to patient management. Third, although conducted in 2 large hospitals, our study was limited to a single region of France, and our results might not be fully representative in other contexts and settings.

Conclusions

In conclusion, our study found that only a small proportion of readmissions following hospitalization for pneumonia were avoidable. Given the complexity of clinical situations, detailed clinical data and multiple independent reviews are essential to judge whether a pneumonia readmission is avoidable. The use of 30-day readmission following a hospitalization for CAP for determining shortcut payments and public reporting may unfairly penalize hospitals.

Back to top
Article Information

Accepted for Publication: February 20, 2022.

Published: April 8, 2022. doi:10.1001/jamanetworkopen.2022.6574

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Boussat B et al. JAMA Network Open.

Corresponding Author: Bastien Boussat, MD, PhD, Service d'épidémiologie et évaluation médicale, CHU Grenoble Alpes, 38043 cedex 9, Grenoble, France (bastien.boussat@ucalgary.ca).

Author Contributions: Drs François and Boussat had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Boussat, Courtois, François.

Acquisition, analysis, or interpretation of data: Boussat, Cazzorla, Le Marechal, Pavese, Mounayar, Sellier, Gaillat, Camara, Degano, Maillet, Bouisse, Seigneurin.

Drafting of the manuscript: Boussat, Cazzorla, François.

Critical revision of the manuscript for important intellectual content: Cazzorla, Le Marechal, Pavese, Mounayar, Sellier, Gaillat, Camara, Degano, Maillet, Courtois, Bouisse, Seigneurin.

Statistical analysis: Boussat, Cazzorla, Bouisse, Seigneurin.

Obtained funding: Camara, François.

Administrative, technical, or material support: Le Marechal.

Supervision: Boussat, Courtois, François.

Conflict of Interest Disclosures: None reported.

Funding/Support: This work was supported by an unrestricted grant from the French Ministry of Health (PREPS-IQ 2013) (No. PREPS1300302).

Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

References
1.
Leppin  AL, Gionfriddo  MR, Kessler  M,  et al.  Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials.   JAMA Intern Med. 2014;174(7):1095-1107. doi:10.1001/jamainternmed.2014.1608PubMedGoogle ScholarCrossref
2.
US Centers for Medicare & Medicaid Services. Hospital Readmissions Reduction Program (HRRP). Revised December 1, 2021. Accessed May 15, 2021. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program
3.
Fonarow  GC, Yancy  CW.  Consequences of reductions in hospital readmissions.   JAMA. 2017;318(19):1933-1934. doi:10.1001/jama.2017.14779PubMedGoogle ScholarCrossref
4.
Fontanarosa  PB, McNutt  RA.  Revisiting hospital readmissions.   JAMA. 2013;309(4):398-400. doi:10.1001/jama.2013.42PubMedGoogle ScholarCrossref
5.
US Centers for Medicare & Medicaid Services. Hospital-Wide (All-Condition) 30-Day Risk-Standardized Readmission Measure. Updated August 10, 2011. Accessed February 15, 2022. https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/mms/downloads/mmshospital-wideall-conditionreadmissionrate.pdf
6.
Gusmano  M, Rodwin  V, Weisz  D, Cottenet  J, Quantin  C.  Comparison of rehospitalization rates in France and the United States.   J Health Serv Res Policy. 2015;20(1):18-25. doi:10.1177/1355819614551849PubMedGoogle ScholarCrossref
7.
Shorr  AF, Zilberberg  MD.  Admitting what we do not know about pneumonia readmissions.   Chest. 2015;148(1):4-6. doi:10.1378/chest.14-2987PubMedGoogle ScholarCrossref
8.
Andruska  A, Micek  ST, Shindo  Y,  et al.  Pneumonia pathogen characterization is an independent determinant of hospital readmission.   Chest. 2015;148(1):103-111. doi:10.1378/chest.14-2129PubMedGoogle ScholarCrossref
9.
van Walraven  C, Jennings  A, Taljaard  M,  et al.  Incidence of potentially avoidable urgent readmissions and their relation to all-cause urgent readmissions.   CMAJ. 2011;183(14):E1067-E1072. doi:10.1503/cmaj.110400PubMedGoogle ScholarCrossref
10.
Lindenauer  PK, Normand  S-LT, Drye  EE,  et al.  Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia.   J Hosp Med. 2011;6(3):142-150. doi:10.1002/jhm.890PubMedGoogle ScholarCrossref
11.
Weinreich  M, Nguyen  OK, Wang  D,  et al.  Predicting the risk of readmission in pneumonia—a systematic review of model performance.   Ann Am Thorac Soc. 2016;13(9):1607-1614. doi:10.1513/AnnalsATS.201602-135SRPubMedGoogle ScholarCrossref
12.
Dely  C, Sellier  P, Dozol  A, Segouin  C, Moret  L, Lombrail  P.  Les réadmissions évitables des pneumopathies communautaires: utilité et fiabilité d’un indicateur de la qualité du parcours de soins du patient.   Presse Med. 2012;41(1):e1-e9. doi:10.1016/j.lpm.2011.06.007PubMedGoogle ScholarCrossref
13.
Shams  I, Ajorlou  S, Yang  K.  A predictive analytics approach to reducing 30-day avoidable readmissions among patients with heart failure, acute myocardial infarction, pneumonia, or COPD.   Health Care Manag Sci. 2015;18(1):19-34. doi:10.1007/s10729-014-9278-yPubMedGoogle ScholarCrossref
14.
Yap  V, Mutneja  R, Metersky  M.  Thirty-day readmissions after pneumonia: how many are preventable?   Conn Med. 2016;80(3):147-151.PubMedGoogle Scholar
15.
Auerbach  AD, Kripalani  S, Vasilevskis  EE,  et al.  Preventability and causes of readmissions in a national cohort of general medicine patients.   JAMA Intern Med. 2016;176(4):484-493. doi:10.1001/jamainternmed.2015.7863PubMedGoogle ScholarCrossref
16.
Herzig  SJ, Schnipper  JL, Doctoroff  L,  et al.  Physician perspectives on factors contributing to readmissions and potential prevention strategies: a multicenter survey.   J Gen Intern Med. 2016;31(11):1287-1293. doi:10.1007/s11606-016-3764-5PubMedGoogle ScholarCrossref
17.
van Walraven  C, Jennings  A, Forster  AJ.  A meta-analysis of hospital 30-day avoidable readmission rates.   J Eval Clin Pract. 2012;18(6):1211-1218. doi:10.1111/j.1365-2753.2011.01773.xPubMedGoogle ScholarCrossref
18.
Mounayar  A-L, Francois  P, Pavese  P,  et al.  Development of a risk prediction model of potentially avoidable readmission for patients hospitalised with community-acquired pneumonia: study protocol and population.   BMJ Open. 2020;10(11):e040573. doi:10.1136/bmjopen-2020-040573PubMedGoogle Scholar
19.
Halfon  P, Eggli  Y, van Melle  G, Chevalier  J, Wasserfallen  J-B, Burnand  B.  Measuring potentially avoidable hospital readmissions.   J Clin Epidemiol. 2002;55(6):573-587. doi:10.1016/S0895-4356(01)00521-2PubMedGoogle ScholarCrossref
20.
Fonarow  GC, Yancy  CW.  Claims data to ascertain clinical events: lost in translation.   JAMA Cardiol. 2017;2(7):758. doi:10.1001/jamacardio.2017.1580PubMedGoogle ScholarCrossref
21.
Kangovi  S, Grande  D.  Hospital readmissions—not just a measure of quality.   JAMA. 2011;306(16):1796-1797. doi:10.1001/jama.2011.1562PubMedGoogle ScholarCrossref
22.
van Walraven  C, Bennett  C, Jennings  A, Austin  PC, Forster  AJ.  Proportion of hospital readmissions deemed avoidable: a systematic review.   CMAJ. 2011;183(7):E391-E402. doi:10.1503/cmaj.101860PubMedGoogle ScholarCrossref
23.
Yam  CHK, Wong  ELY, Chan  FWK, Wong  FYY, Leung  MCM, Yeoh  EK.  Measuring and preventing potentially avoidable hospital readmissions: a review of the literature.   Hong Kong Med J. 2010;16(5):383-389.PubMedGoogle Scholar
24.
Ashton  CM, Wray  NP.  A conceptual framework for the study of early readmission as an indicator of quality of care.   Soc Sci Med. 1996;43(11):1533-1541. doi:10.1016/S0277-9536(96)00049-4PubMedGoogle ScholarCrossref
25.
Capelastegui  A, España  PP, Bilbao  A,  et al.  Pneumonia: criteria for patient instability on hospital discharge.   Chest. 2008;134(3):595-600. doi:10.1378/chest.07-3039PubMedGoogle ScholarCrossref
26.
Capelastegui  A, España Yandiola  PP, Quintana  JM,  et al.  Predictors of short-term rehospitalization following discharge of patients hospitalized with community-acquired pneumonia.   Chest. 2009;136(4):1079-1085. doi:10.1378/chest.08-2950PubMedGoogle ScholarCrossref
27.
Halm  EA, Fine  MJ, Kapoor  WN, Singer  DE, Marrie  TJ, Siu  AL.  Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia.   Arch Intern Med. 2002;162(11):1278-1284. doi:10.1001/archinte.162.11.1278PubMedGoogle ScholarCrossref
28.
Hatipoğlu  U, Wells  BJ, Chagin  K, Joshi  D, Milinovich  A, Rothberg  MB.  Predicting 30-day all-cause readmission risk for subjects admitted with pneumonia at the point of care.   Respir Care. 2018;63(1):43-49. doi:10.4187/respcare.05719PubMedGoogle ScholarCrossref
29.
Pederson  JL, Warkentin  LM, Majumdar  SR, McAlister  FA.  Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: a systematic review and meta-analysis.   J Hosp Med. 2016;11(5):373-380. doi:10.1002/jhm.2547PubMedGoogle ScholarCrossref
30.
Rudolph  BA, Miller  N.  Cost of care for diabetes in Wisconsin hospitals and ambulatory surgery centers in 1996.   WMJ. 1998;97(3):55-57.PubMedGoogle Scholar
31.
Shorr  AF, Zilberberg  MD, Reichley  R,  et al.  Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals.   Clin Infect Dis. 2013;57(3):362-367. doi:10.1093/cid/cit254PubMedGoogle ScholarCrossref
32.
Chin  DL, Bang  H, Manickam  RN, Romano  PS.  Rethinking thirty-day hospital readmissions: shorter intervals might be better indicators of quality of care.   Health Aff (Millwood). 2016;35(10):1867-1875. doi:10.1377/hlthaff.2016.0205PubMedGoogle ScholarCrossref
33.
Sauro  K, Ghali  WA, Stelfox  HT.  Measuring safety of healthcare: an exercise in futility?   BMJ Qual Saf. 2020;29(4):341-344. doi:10.1136/bmjqs-2019-009824PubMedGoogle ScholarCrossref
34.
Boussat  B, Quan  H, Labarere  J, Southern  D, Couris  CM, Ghali  WA.  Mitigating imperfect data validity in administrative data PSIs: a method for estimating true adverse event rates.   Int J Qual Health Care. 2021;33(1):mzab025. doi:10.1093/intqhc/mzab025PubMedGoogle Scholar
35.
Makam  AN, Nguyen  OK, Clark  C,  et al.  Predicting 30-day pneumonia readmissions using electronic health record data.   J Hosp Med. 2017;12(4):209-216. doi:10.12788/jhm.2711PubMedGoogle ScholarCrossref
36.
Fairie  P, Zhang  Z, D’Souza  AG, Walsh  T, Quan  H, Santana  MJ.  Categorising patient concerns using natural language processing techniques.   BMJ Health Care Inform. 2021;28(1):e100274. doi:10.1136/bmjhci-2020-100274PubMedGoogle Scholar
37.
Lee  S, Doktorchik  C, Martin  EA,  et al.  Electronic medical record-based case phenotyping for the Charlson conditions: scoping review.   JMIR Med Inform. 2021;9(2):e23934. doi:10.2196/23934PubMedGoogle Scholar
38.
Burke  RE, Jones  CD, Hosokawa  P, Glorioso  TJ, Coleman  EA, Ginde  AA.  Influence of nonindex hospital readmission on length of stay and mortality.   Med Care. 2018;56(1):85-90. doi:10.1097/MLR.0000000000000829PubMedGoogle ScholarCrossref
×